mb-cart-19.1
Cell therapyexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Feb 12, 2025 (NCT07271121)
Timeline
2020s
- Jan 1, 2025
Earliest Phase 2 Sponsor(trial)
Mechanism of action
- B-lymphocyte antigen CD19Immunity, passive
CD19 immunity, passive
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07271121 | Phase 2 | Feb 12, 2025 | King Hussein Cancer Center |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| King Hussein Cancer Center | Academic/Hospital | 1 | 1 | 1 | 2025 |
1 organizations
Page 1 / 1